Jpmorgan Chase & CO Royalty Pharma PLC Transaction History

Jpmorgan Chase & CO

$1.1 Trillion
Q1 2024

A detailed history of Jpmorgan Chase & CO transactions in Royalty Pharma PLC stock. As of the latest transaction made, Jpmorgan Chase & CO holds 7,995,099 shares of RPRX stock, worth $211 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

7,995,099

Previous 8,700,319 8.11%

Holding current value

$211 Million

Previous $244 Million 0.65%

% of portfolio

0.02%

Previous 0.03%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$27.46 - $31.33 $19.4 Million - $22.1 Million	-705,220 Reduced 8.11%	7,995,099 $243 Million
Q4 2023 Feb 12, 2024	SELL	$26.21 - $29.22 $4.91 Million - $5.47 Million	-187,248 Reduced 2.11%	8,700,319 $244 Million
Q3 2023 Nov 14, 2023	BUY	$26.26 - $31.38 $3.98 Million - $4.75 Million	151,396 Added 1.73%	8,887,567 $241 Million
Q2 2023 Aug 11, 2023	BUY	$29.6 - $36.56 $1.91 Million - $2.36 Million	64,608 Added 0.75%	8,736,171 $269 Million
Q1 2023 May 18, 2023	BUY	$32.77 - $39.4 $502,036 - $603,608	15,320 Added 0.18%	8,671,563 $312 Million

Q1 2023 May 11, 2023	BUY	$32.77 - $39.4 $7.59 Million - $9.12 Million	231,496 Added 2.75%	8,656,243 $312 Million
Q4 2022 Feb 13, 2023	BUY	$39.17 - $44.04 $3.65 Million - $4.1 Million	93,150 Added 1.12%	8,424,747 $333 Million
Q3 2022 Nov 14, 2022	BUY	$39.88 - $44.65 $27.3 Million - $30.5 Million	683,612 Added 8.94%	8,331,597 $335 Million
Q2 2022 Aug 11, 2022	BUY	$37.53 - $44.22 $78.4 Million - $92.4 Million	2,088,597 Added 37.57%	7,647,985 $322 Million
Q1 2022 May 11, 2022	BUY	$37.46 - $42.44 $5.14 Million - $5.82 Million	137,185 Added 2.53%	5,559,388 $217 Million
Q4 2021 Feb 10, 2022	BUY	$35.17 - $42.48 $3.72 Million - $4.49 Million	105,721 Added 1.99%	5,422,203 $216 Million
Q3 2021 Nov 12, 2021	BUY	$36.14 - $42.24 $192 Million - $225 Million	5,316,482 New	5,316,482 $192 Million

Others Institutions Holding RPRX

# of Institutions

394

Shares Held

275M

Call Options Held

276K

Put Options Held

236K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $11.5B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Royalty Pharma PLC Transaction History